Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

New isatin-gallate hybrids show promise as antioxidants, cancer treatments, and coronavirus inhibitors.

Dermatologists are hesitant to prescribe Janus kinase inhibitors for alopecia areata due to safety concerns and lack of knowledge.

MK-386 lowers DHT in blood and skin but not in semen.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

GI197111X is best dissolved in Capmul MCM for trials.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

Baricitinib successfully treated severe hair loss.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Finasteride helps female-pattern hair loss.

AC-5216 reduces anxiety in mice through neurosteroids affecting GABAA receptors.

Two new compounds were found to effectively reduce hair growth in mice.